{
  "risk_score_0_to_1": 0.05,
  "confidence_0_to_1": 0.95,
  "dominant_mechanisms": [
    {"mechanism": "mitochondrial_dysfunction", "score_0_to_1": 0.4},
    {"mechanism": "reactive_metabolite_formation", "score_0_to_1": 0.0},
    {"mechanism": "cholestasis_bsep_inhibition", "score_0_to_1": 0.05},
    {"mechanism": "immune_mediated_injury", "score_0_to_1": 0.05},
    {"mechanism": "oxidative_stress", "score_0_to_1": 0.1}
  ],
  "time_to_onset": "unknown",
  "dose_dependence": "not_applicable",
  "reversibility": "not_applicable",
  "uncertainties": [
    "Mechanism of rare idiosyncratic hepatotoxicity reports remains poorly understood",
    "Potential protective effect against NAFLD vs. direct mitochondrial stress"
  ],
  "citations": [
    "He, L., et al. (2009). Metformin and insulin suppression of hepatic gluconeogenesis through phosphorylation of CREB-binding protein.",
    "LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Metformin."
  ]
}